Candida albicans PLD1 activity is required for full virulence

被引:41
作者
Dolan, JW
Bell, AC
Hube, B
Schaller, M
Warner, TF
Balish, E
机构
[1] Med Univ S Carolina, Coll Dent Med, Dept Stomatol, Charleston, SC 29425 USA
[2] Univ Wisconsin, Sch Med, Dept Clin Pathol, Madison, WI USA
[3] Robert Koch Inst, D-1000 Berlin, Germany
[4] Univ Munich, Dept Dermatol, D-8000 Munich, Germany
关键词
Candida; phospholipase D1; virulence; morphogenesis;
D O I
10.1080/13693780410001657162
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Phospholipase D1 (PLD1) mutants of Candida albicans are defective in important in vivo and in vitro virulence factors. PLD1 mutants colonize the murine alimentary tract as well as PLD1 sufficient strains. In comparison to PLD1 sufficient strains, the PLD1 mutants: (1) are unable to survive in internal organs after intravenous challenge; (ii) do not decrease the body weights of mice after oral challenge; and (111) are riot lethal for immunodeficient mice after oral challenge. In vitro, the PLD1 mutants show a drastically reduced capacity to penetrate epithelial monolayers and they fail to develop hyphae when grown on solid Spider medium. The morphogenic switch from yeast to hyphae is controlled by multiple parallel signaling pathways that couple specific stimuli to the regulation of several transcription factors. Our data suggest that PLD1 functions in at least one of these pathways regulating morphogenesis in vitro and that while the mutants are able to form hyphae in vivo, the hyphae are defective in their ability to cause oroesophageal and gastric candidiasis and to kill the C albicans-colonized mice.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 26 条
[21]  
SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
[22]   Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi [J].
Stoldt, VR ;
Sonneborn, A ;
Leuker, CE ;
Ernst, JF .
EMBO JOURNAL, 1997, 16 (08) :1982-1991
[23]   Early resistance of interleukin-10 knockout mice to acute systemic candidiasis [J].
Vazquez-Torres, A ;
Jones-Carson, J ;
Wagner, RD ;
Warner, T ;
Balish, E .
INFECTION AND IMMUNITY, 1999, 67 (02) :670-674
[24]   A BLOCK IN BOTH EARLY T-LYMPHOCYTE AND NATURAL-KILLER-CELL DEVELOPMENT IN TRANSGENIC MICE WITH HIGH-COPY NUMBERS OF THE HUMAN CD3E GENE [J].
WANG, BP ;
BIRON, C ;
SHE, J ;
HIGGINS, K ;
SUNSHINE, MJ ;
LACY, E ;
LONBERG, N ;
TERHORST, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9402-9406
[25]   THE USE OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA [J].
WINGARD, JR .
LEUKEMIA & LYMPHOMA, 1992, 8 (4-5) :353-359
[26]  
ZUPI G, 1988, CANCER RES, V48, P6193